Details for 2019158371

Up to date per 04.04.2026

Actions

Title / Product Name

7-BENZYL-4-(2-METHYLBENZYL)-2,4,6,7,8,9-HEXAHYDROIMIDAZO[1,2-A]PYRIDO[3,4-E]PYRIMIDIN-5(1H)-ON, SALZE DAVON UND VERFAHREN ZUR VERWENDUNG DAVON IN DER KOMBINATIONSTHERAPIE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019158371

EP Publication Number

3546461

E-Number

1419277

Language

PCT Number

Publication Date

02.10.2019 A

11.08.2021 B1

Registration Date

11.08.2021

AT Publication Date

15.09.2021

Application Date

12.09.2014

Registration Number

Priorities

15.11.2013

201361904718 P

13.03.2014

201414208657

25.07.2014

201414341392

25.07.2014

PCT/US2014/048241

IPC

C07D 471/14 20060101AFI20190827BHEP

Maximum Duration of Protection

12.09.2034

Owner

Oncoceutics, Inc.3675 Market Street Suite 200 Philadelphia, PA 19104US

Representative

Dipl.-Ing. Werner Barger, Dipl.-Ing. Dr. techn. Peter IsrailoffOperngasse 41010 WienAT

Inventor

STOGNIEW, Martin1870 Ferguson Lane Blue Pell, PA 19422US

ALLEN, Joshua E.43 Chestnut St., Unit 311 New Haven, CT 06511US

POTTORF, Richard S.7550 Prairie View Dr. Indianapolis, IN 46526US

NALLAGANCHU, Bhaskara Rao99 Nostrand Road Hillsborough, NJ 08852US

OLSON, Gary L.1505 Coles Avenue Mountainside, NJ 07092US

Information about Fees